Get the Stockscreener App
1.10
2.65%
-0.03
After Hours:
1.10
Sonoma Pharmaceuticals Inc Stock (SNOA) Forecast
The Sonoma Pharmaceuticals Inc (SNOA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.0327, representing a +175.70% increase from the current price of $1.10. The highest analyst price target is $3.6321, and the lowest is $2.4333.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SNOA Price Target
Average 4.52
(+310.91% Upside)
Is Sonoma Pharmaceuticals Inc (SNOA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.69 | Neutral |
| STOCH(9,6) | 15.77 | Buy |
| STOCHRSI(14) | 11.35 | Buy |
| MACD(12,26) | -0.0136 | Sell |
| ADX(14) | 14.48 | Neutral |
| William %R | -87.50 | Buy |
| CCI(14) | -90.20 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.176
Sell
|
1.1701
Sell
|
| MA20 |
1.207
Sell
|
1.1828
Sell
|
| MA50 |
1.1545
Sell
|
1.2714
Sell
|
| MA100 |
1.5655
Sell
|
1.6165
Sell
|
| MA200 |
2.5062
Sell
|
2.1611
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SNOA could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on SNOA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.69 indicates that SNOA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.77 indicates that SNOA is oversold. This indicates that SNOA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.35 indicates that SNOA is oversold. This suggests that SNOA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.48 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -90.2 indicates that SNOA is still oversold but not to an extreme extent.
Long-term SNOA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sonoma Pharmaceuticals Inc financial reports and earnings history, Sonoma Pharmaceuticals Inc (SNOA) stock could reach $7.75 by 2030, $4.4127 by 2040 and $14.33 by 2050. See the projected annual prices until 2050 of the Sonoma Pharmaceuticals Inc stock below:
- Sonoma Pharmaceuticals Inc (SNOA) is expected to reach an average price of $1.564 in 2035, with a high prediction of $1.7388 and a low estimate of $1.5938. This indicates an $42.19% rise from the last recorded price of $1.10.
- Sonoma Pharmaceuticals Inc (SNOA) stock is projected to chart a bullish course in 2040, with an average price target of $4.264, representing an $287.64% surge from its current level. The forecast ranges from a conservative $4.2723 to a sky-high $4.4127.
- Our analysts predict Sonoma Pharmaceuticals Inc (SNOA) to jump 650.82% by 2045, soaring from $7.7992 to an average price of $8.2591, potentially reaching $8.1915. While $7.7992 is the low estimate, the potential upside is significant.
- Sonoma Pharmaceuticals Inc (SNOA) stock is expected to climb by 2050, reaching an average of $14.04, a $1,176% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.33 and $14.44, respectively, highlighting the market's uncertainty.
Sonoma Pharmaceuticals Inc Stock (SNOA) Year by Year Forecast
Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2026
The predicted value for Sonoma Pharmaceuticals Inc (SNOA) in 2026 is set at an average of $5.2991. Estimates vary from a peak of $9.8941 to a trough of $0.7041, indicating an +381.73% surge from the present price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2026 | $2.7933 | $2.4333 | $3.6321 | +153.93% |
| October, 2026 | $1.2957 | $0.9345 | $5.2789 | +17.79% |
| November, 2026 | $2.0681 | $0.9169 | $9.0369 | +88.01% |
| December, 2026 | $1.4361 | $0.9805 | $4.6161 | +30.55% |
Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sonoma Pharmaceuticals Inc (SNOA) is $1.568, with a high forecast of $3.1329 and a low forecast of $0.0031. This indicates an +42.54% increase from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.5085 | $1.1173 | $3.1329 | +37.14% |
| February, 2027 | $1.5809 | $1.2709 | $2.7753 | +43.72% |
| March, 2027 | $0.9989 | $0.3634 | $1.6465 | -9.19% |
| April, 2027 | $0.8913 | $0.5313 | $1.2201 | -18.97% |
| May, 2027 | $0.3087 | $0.0031 | $0.9069 | -71.94% |
| June, 2027 | $0.5283 | $0.1393 | $0.4493 | -51.97% |
| July, 2027 | $0.6341 | $0.2259 | $0.7641 | -42.35% |
| August, 2027 | $0.4635 | $0.1247 | $0.6397 | -57.87% |
| September, 2027 | $0.2245 | $0.0545 | $1.0789 | -79.59% |
| October, 2027 | $0.0269 | $0.1017 | $0.5457 | -97.55% |
| November, 2027 | $0.0293 | $0.0819 | $0.1427 | -97.33% |
| December, 2027 | $0.4703 | $0.0739 | $1.3517 | -57.24% |
Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2028
In 2028, Sonoma Pharmaceuticals Inc (SNOA) is projected to reach an average price of $0.5571, with a high projection of $1.0739 and a low estimate of $0.0403. This indicates an -49.36% fall from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0997 | $0.0403 | $0.6829 | -90.93% |
| February, 2028 | $0.4779 | $0.0453 | $0.3679 | -56.56% |
| March, 2028 | $0.4899 | $0.5223 | $0.4691 | -55.47% |
| April, 2028 | $0.5775 | $0.4931 | $0.8857 | -47.50% |
| May, 2028 | $1.0995 | $0.6963 | $0.9195 | -0.05% |
| June, 2028 | $0.9171 | $0.9871 | $1.0739 | -16.63% |
| July, 2028 | $0.5047 | $0.4459 | $0.5585 | -54.12% |
| August, 2028 | $0.9566 | $0.5879 | $0.7466 | -13.03% |
| September, 2028 | $0.8742 | $0.8936 | $0.8291 | -20.52% |
| October, 2028 | $0.7418 | $0.7918 | $0.7286 | -32.56% |
| November, 2028 | $0.617 | $0.6537 | $0.6457 | -43.91% |
| December, 2028 | $0.4114 | $0.3326 | $0.3314 | -62.60% |
Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2029
The 2029 price forecast for Sonoma Pharmaceuticals Inc Stock (SNOA) is $3.6837 on average, with a high prediction of $7.3436 and a low estimate of $0.0238. This represents an +234.88% increase from the previous price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2734 | $0.2734 | $0.3258 | -75.14% |
| February, 2029 | $0.406 | $0.3405 | $0.361 | -63.09% |
| March, 2029 | $0.2008 | $0.2542 | $0.2954 | -81.74% |
| April, 2029 | $0.2762 | $0.3442 | $0.2969 | -74.89% |
| May, 2029 | $0.7776 | $0.4356 | $0.7694 | -29.31% |
| June, 2029 | $0.6408 | $0.6503 | $0.7207 | -41.74% |
| July, 2029 | $0.533 | $0.5517 | $0.5758 | -51.54% |
| August, 2029 | $0.4003 | $0.4432 | $0.4942 | -63.61% |
| September, 2029 | $0.337 | $0.339 | $0.3747 | -69.36% |
| October, 2029 | $0.214 | $0.2239 | $0.2997 | -80.54% |
| November, 2029 | $0.1026 | $0.1046 | $0.1388 | -90.67% |
| December, 2029 | $7.5236 | $0.0238 | $7.3436 | +583.96% |
Sonoma Pharmaceuticals Inc Stock (SNOA) Price Forecast for 2030
Sonoma Pharmaceuticals Inc Stock (SNOA) is expected to reach an average price of $8.439 in 2030, with a high forecast of $9.344 and a low forecast of $7.534. This signifies an +667.18% surge from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.2756 | $7.9073 | $7.75 | +652.33% |
| February, 2030 | $8.1528 | $7.534 | $7.3928 | +641.16% |
| March, 2030 | $8.568 | $8.5904 | $8.388 | +678.91% |
| April, 2030 | $7.6832 | $8.2432 | $8.6356 | +598.47% |
| May, 2030 | $8.4672 | $8.2096 | $7.9172 | +669.74% |
| June, 2030 | $8.9524 | $9.0124 | $8.9301 | +713.85% |
| July, 2030 | $8.7664 | $7.8024 | $7.7764 | +696.94% |
| August, 2030 | $9.5416 | $9.5616 | $9.344 | +767.41% |
| September, 2030 | $9.1367 | $9.1079 | $9.0392 | +730.61% |
| October, 2030 | $8.0521 | $8.1007 | $8.0955 | +632.01% |
| November, 2030 | $8.0659 | $7.9471 | $7.3083 | +633.27% |
| December, 2030 | $7.6845 | $8.0323 | $7.4347 | +598.59% |
2.08%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):